Scientific Evidence Module 2. The evidence of effectiveness Most research is on methadone, much less on other medications Has proven effective for the.

Slides:



Advertisements
Similar presentations
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Advertisements

Substance Use Disorder Treatment Supporting the Field with Evidence and Logic.
SAMH Mental Health & Alcohol Conference Transforming the concept of Dual Diagnosis to the concept of Complex Needs Dr Fraser Shaw Consultant Psychiatrist.
 Centre for Drug Misuse Research Glasgow Scotland From Harm Reduction to Abstinence: A Journey in Drug Treatment Pol From Harm Reduction to Abstinence:
Models of Evaluation of Addiction Treatment Outcome Post-Treatment vs. During Treatment Evaluation of Effectiveness.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
 William Frank Barker, LPC, MAC Diane Diver, LMSW, CAC II.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse What Do We Know? Drug Abuse.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2009.
Addiction Treatment Outcomes Prof Michael Gossop National Addiction Centre Maudsley Hospital/Institute of Psychiatry.
Copyright Alcohol Medical Scholars Program 1 Opioid Agonist Treatment: “Trading one substance for another?” Joseph Sakai, M.D.
Methadone in Opioid Addiction David Kan, M.D. University of California San Francisco VA Medical Center San Francisco.
Developments in Community - Based Drug Treatments Lesley Peters
EYES ON THE FUTURE Be part of the Solution Come to debate and innovate ! 12 th EFTC CONGRES The Hague, The Netherlands 2 nd – 5 th June 2009.
.  Introduction to Methadone Maintenance Therapy (MMT)  Introduction to Harm Reduction  Benefits of MMT  One Patient’s Perspective  Misconceptions.
Opiate Substitution Treatment: An Overview Ron Jackson, M.S.W. Evergreen Treatment Services Seattle, WA.
Substitution Treatment for Opiate Dependence in Europe Annette Verster Montego Bay August 2001.
4th Annual Thoughtful Pain Management
Substitute Prescribing Paul Smith BS.c Addiction Counselling.
Pain Management for Patients in OTPs. Pain Prevalence Study of (2) populations 1 –(390) pts in MMT –(531) pts in short term residential –Prevalence of.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
Harm Reduction Presented by Mike Nielsen. Introduction Brief History Brief History Definition Definition Relationship to Therapy Relationship to Therapy.
Using Research/Evaluation Questions to Define Data Collection and Findings: Findings from the FY 2004 KTOS Follow-up Study Robert Walker, Allison Mateyoke-Scrivener,
IMPACT OF EDUCATIONAL INTERVENTION ON PRESCRIBING BEHAVIOUR AND COST OF THERAPY IN BRONCHIAL ASTHMA IN COLONY HOSPITALS OF DELHI Kotwani A, Gupta U, Suri.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
Good Prescribing to support Criminal Justice Interventions
European Society of Cardiology Cardiovascular diseases in women.
OPIOID SUBSTITUTION THERAPY
The Value of Medication Therapy Management Services.
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
By Ameya Nerurkar Mandar Samant Chih-Pin Hsiao
THE UNIVERSITY OF SHEFFIELD INSTITUTE OF GENERAL PRACTICE & PRIMARY CARE HOW DO WE GET THE BEST OUT OF METHADONE PROGRAMMES? DR JENNY KEEN Clinical Director.
Dundee Partnership Community Conference 17 th September 2011 What are we trying to achieve? The national picture Dr Brian Kidd – NHS Tayside.
Eagleville Hospital Methadone Induction Christine Falcone, RN, Director of Quality Management/Patient Safety Officer Charlie Folks, Director of Counseling.
“The whole is greater than the sum of its parts” Dr Mark Lawton Medical Lead Coventry Rachel Abbott Volunteer and Training Co-ordinator.
Methadone ? Methadone and Treatment By: Eleu Pontes CSW.
Physicians’ Attitudes to Methadone Maintenance Treatment in Nova Scotia Jessica Dooley*, M.Sc. Candidate Dr. Susan Kirkland*, Ph. D. Dr. Mark Asbridge*,
Commissioning Update – Specifications, Performance and Funding Ben Seale January 2012.
The cost of problem substance use Cost of illicit drug use £3.5bn Cost of alcohol misuse total £2.25bn.
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
Databases Using them to study MS in the UK. Proposed research using: GPRD (General Practice Research Database) MSNTC Northwood Database.
Delivery Systems for Substance Abuse Treatment: Integration with Primary Care and Mental Health and Social Services (Also referred to as) Delivery Systems.
A prevalence study of alcohol amongst offenders in the probation and prison services in North East England Dr. Dorothy Newbury-Birch Senior Research Associate.
Module 1 General introduction to substitution treatment.
 Methadone is prescribed to relieve moderate to severe pain that has not been relieved by non-narcotic pain relievers.
NYSDOH/AI The Role of Methadone in HIV Prevention And Treatment Sharon Stancliff, MD Medical Consultant AIDS Institute New York State Department of Health.
BACLOFEN AS AN ADJUNCT PHARMACOTHERAPY FOR THE MAINTENANCE OF ABSTINENCE IN ALCOHOL DEPENDENT PATIENTS WITH ESTABLISHED LIVER DISEASE Lynn Owens 1, Abi.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
The financial costs and benefits of alcohol The financial costs and benefits of alcohol Christine Godfrey Department of Health Sciences & Centre for Health.
Clinical aspects Module 4. Steps Assessment Criteria for treatment Treatment plan Induction Monitoring Evaluation.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Principles of Effective Drug Addiction Treatment Health 10 The Truth About Drugs Ms. Meade.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS State of the art and new perspectives in drug addiction treatment Dr L Michel, MD, PhD Inserm U1178.
NTA, 20/11/2012 MEDICATIONS IN RECOVERY: RE-ORIENTATING DRUG DEPENDENCE TREATMENT Report of the Recovery Orientated Drug Treatment Expert Group.
FAMILY RECOVERY NETWORK EVENT: What is Substance Abuse Treatment? Patrick Seche, MS, CASAC Strong Recovery Addiction Psychiatry Division Department of.
A Cost-Benefit Assessment of Abuse Deterrent Opioids Wayne Winegarden, Ph.D. Sr. Fellow, Business & Economics, Pacific Research Institute Contributing.
Challenges and Opportunities for the Use of Medications to Treat Chronic Opioid Addiction in the United States Mark W. Parrino, M.P.A. Thursday, April.
© 2015 Omnicell, Inc. Content is confidential and proprietary 1 The Benefits of Multimed Adherence Packaging Add Your Logo Here.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Dr Sue Pritchard Shipston Medical Centre.  Chronic relapsing condition – similar to others treated in primary care  Mortality 14 x higher for age matched.
People with chronic pain are often prescribed methadone, a type of analgesic medicine to reduce pain. This medicine is also given.
Drugs and Neuron Communication
Unveil the importance of pain management in cancer patients
A State Targeted Response to the Opioid Crisis:
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Strategic Initiatives to Address Opioid Overdose & Addiction
Medically assisted treatment
Medication Assisted Treatment of Opioid Use Disorder
Presentation transcript:

Scientific Evidence Module 2

The evidence of effectiveness Most research is on methadone, much less on other medications Has proven effective for the individual Has proven effective for society at large

Large body of evidence JC Ball and A Ross (1991). The effectiveness of Methadone Maintenance Treatment. New York: Springer Verlag M Farrell, J Ward, R Mattick, W Hall, G Stimson, D des Jarlais, M Gossop, J Strang (1994). Methadone Maintenance Treatment in Opiate Dependence: a Review. BMJ 309: A Preston (1996). The Methadone Briefing J Ward, R Mattick, W Hall (1998). Methadone Maintenance Treatment and other Opioid Replacement Therapies. Harwood Academic Publishers, Amsterdam, The Netherlands H Joseph, S Stancliff, J Langrod (2000). Methadone Maintenance Treatment (MMT): A review of Historical and Clinical Issues. In: the Mount Sinai Journal of Medicine Vol.67 Nos 5&6

Effectiveness for the individual Stay alive Achieve abstinence or a stabilised pattern of use Stabilise social live Improve physical health Reduce criminal activity

Effectiveness for society Improve public health Reduce emergencies, hospitalisations Reduce spread of HIV and other infectious diseases Reduce social welfare costs Reduce costs in criminal justice system

What are the cost–benefits of ST? DASA, NYC, 1991 estimated the annual costs of opiate addicts: –Untreated on the street€ –In prison€ –In residential TC€ –In methadone maintenance€ 2.500

Costs-benefits 2 DASA calculated the effects of ST in 2001 in reductions of: 64% in property crimes 54% overall arrests 63% drug offence arrests 65% emergency room visits 59% medical hospitalisations 55% psychiatric hospitalisations

Cost – benefits 3 Collaboration between departments is important because spending in one can yield savings in another: –NTORS (UK,1998): Every €1,5 spent on treatment (health) return €4,5 savings in costs of crime (criminal justice)

Chronic versus acute care Opiate dependence often chronic condition Treatment for many patients needs to be chronic too Effectiveness higher with long term treatment at adequate dosage and provided properly

Source: McLellan, Treatment Research Institute, USA Outcome in hypertension

Source: McLellan, Treatment Research Institute, USA Outcome in addiction

Comprehensive treatment Assessment of co-morbidity Assessment of psycho-social problems Treatment of these issues

Limitations Being stable on agonist medication can cause dependency to treatment and to the doctor Substitution treatment is often not considered as valid as recovery to abstinence It is corrective rather than curative However, these limitations do not outweigh the benefits

Limitations of prescribing There are some side effects (e.g. increased transpiration, constipation, and disturbances of sleep, sex drive and concentration) which affect 20% of patients They are however without medical consequences Methadone helps around 70% of patients Despite the scientific basis, there is no consensus in practice, leading to contradictory or excessively rigid practice Existing oral formulations are not well designed and unpopular

Conclusions As drug addiction is a condition not easy to overcome, it is important to reduce the harm both to society at large and to the individual patient Scientific evidence has shown that good quality substitution treatment available for anybody who needs it can save many other costs in health care, social welfare and the criminal justice system.